Turmeric

What is turmeric?

Curcuma longa belongs to the ginger family. The part used is its rhizome, an underground stem. Curcumin is a yellow constituent within the curcuminoid group. Long culinary and traditional use explains research interest but does not replace clinical efficacy testing. [1]

The EMA monograph covers specified traditional herbal medicines for mild digestive problems such as fullness or flatulence. This classification rests on long-standing use. It does not recognise every extract or establish efficacy of food supplements for osteoarthritis. [2]

Rhizome powder is not curcumin

A label should distinguish the amount of plant material, extract and actual curcuminoids. A purely arithmetic example: 500 mg extract declared to contain 20% curcuminoids provides 100 mg curcuminoids. The same calculation cannot be applied to 500 mg rhizome powder without analytical information.

Formulation adds another layer. A pharmacokinetic study found that combining 2 g curcumin with 20 mg piperine substantially increased measured availability compared with curcumin alone. It measured absorption, not treatment of disease. Those experimental quantities are not intake recommendations. [10]

A higher blood concentration does not by itself show the size of a health benefit or a more favourable balance of benefit and risk. Comparing two packages solely by milligrams is similarly inadequate when their preparations differ.

What makes a comparison informative?

Reliable comparison requires traceable botanical identity, plant part, extraction method, standardisation and additional ingredients. Without this information, a trial cannot reliably support another preparation. A positive result for a specific formulation initially belongs to that formulation.

It also matters what was measured: reported pain, mobility, imaging and long-term joint change answer different questions. A change in a laboratory marker alone does not mean that people can walk more easily or experience less pain in daily life.

How much, and what does EFSA say?

Turmeric has no established daily nutritional requirement. The frequently cited EFSA value concerns curcumin as food colour E 100: an acceptable daily intake (ADI) of 3 mg/kg body weight. It follows the JECFA assessment of 0–3 mg/kg. [4]

An ADI is a toxicological assessment of longer-term exposure. It is neither a nutritional target nor a recommended amount for treating joint symptoms. It is not a blanket safety clearance for formulations designed to increase absorption. [4]

What does knee osteoarthritis research show?

What matters for safety?

ANSES documented 15 reports of liver effects potentially associated with turmeric or curcumin food supplements. Reporting systems identify safety signals; they do not provide a reliable event rate per user. [5]

The TGA warns of rare, sometimes severe liver injury with these preparations. Yellowing skin or eyes, dark urine or unusual fatigue require stopping the preparation and seeking medical advice. It advises avoiding such preparations with current or previous liver problems. Ordinary amounts used as a food spice have a different context. [6]

Food supplements containing turmeric may be unsafe during pregnancy. There is insufficient safety information for amounts above ordinary food use during breastfeeding. [1]

What changed in 2026?

The EMA addendum published in 2026 reviewed new safety data. It did not require changing the existing monograph, while discussing risks associated with high curcuminoid amounts or enhanced bioavailability. Interactions involving absorption enhancers warrant further consideration at the next review. [3]

That conclusion applies to the defined scope of the monograph. It does not contradict warnings about differently formulated food supplements. For an individual decision, the complete ingredient list therefore matters more than a shortened statement that turmeric is inherently safe because it is a plant.

Useful details for a professional discussion include the product name, daily serving, curcuminoid content, additions such as piperine, all medicines and the reason for taking it. A short trial does not justify daily use without a defined objective and a planned point for reassessment.